MedTrace Logo

Effect of Power Wheelchairs on the Development and Function of Young Children With Severe Physical Disabilities

NCT01115998 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2016-12-05

Study results available
· View outcomes & findings →

Summary

Self-produced locomotion often is limited in children with cerebral palsy and other conditions that cause severe motor impairments. As a result, these children may be at risk for secondary impairments in spatial cognition, communication, social development, and other domains influenced by independent mobility. To compensate, power mobility has increasingly been advocated for young children with severe motor impairments. The study hypotheses were:

1. Children with severe disabilities that prevent independent locomotion who learn to use power mobility devices when they are 14- to 30-months-of-age will have greater communication, social, and cognitive development over a 12-month period, and will demonstrate more competent coping skills than children with the same characteristics who do not use power mobility.
2. Parents of children who use power mobility will view it as a positive influence on their children's lives, and will perceive their children's development to be more mature than the parents of children who do not use power mobility will perceive their children's development.

Conditions

  • Cerebral Palsy
  • Child, Preschool

Interventions

OTHER

Power wheelchair

Children used power wheelchairs for one year. They continued to receive their usual early intervention services.

OTHER

No power wheelchairs

Children in the control group did not use power wheelchairs. They continued to receive their usual early intervention services.

Sponsors & Collaborators

  • U.S. Department of Education

    collaborator FED

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Irene R McEwen, PT, PhD · University of Oklahoma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Months
Max Age
30 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2004-12-31
Completion
2004-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01115998 on ClinicalTrials.gov